2021

1. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

   Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252